tetramethylpyrazine has been researched along with cabozantinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Huang, J; Huang, Q; Li, Y; Luo, Y; Wang, C; Wu, W; Yu, L; Zha, D; Zhang, C; Zhang, J; Zhou, W | 1 |
1 other study(ies) available for tetramethylpyrazine and cabozantinib
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrazines; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2021 |